Anticoagulation and thromboembolic risk in critically ill patients with trigger-induced atrial fibrillation-A systematic review and meta-analysis.

ABSTRACT:

Introduction

In critically ill patients with trigger-induced atrial fibrillation, there are no definitive recommendations on the use of anticoagulation. This study aimed to evaluate the association between anticoagulation therapy and outcomes (i.e. thromboembolism, bleeding and mortality) and examine prescription patterns in high-risk individuals based on CHA₂DS₂-VASc scores.

Methods

A systematic search was conducted to identify studies reporting on anticoagulation prescription, thromboembolism, bleeding, and mortality. Anticoagulation rates and CHA₂DS₂-VASc scores were correlated, and a meta-analysis was conducted to compare short- and long-term outcomes.

Results

Anticoagulation prescription rates ranged from 3 to 86%; in o

SUBMITTER: Koolwijk J 

PROVIDER: S-EPMC12454756 | biostudies-literature | 2025 Oct

REPOSITORIES: biostudies-literature